or Try an Advanced Search...

    Technical Analysis for AEON - AEON Biopharma, Inc.

    Grade Last Price % Change Price Change
    F 0.56 -2.83% -0.02
    AEON closed down 2.83 percent on Wednesday, November 20, 2024, on 66 percent of normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical AEON trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 0.00%
    New Downtrend Bearish 0.00%
    New 52 Week Low Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish -2.83%
    Spinning Top Other -2.83%
    NR7 Range Contraction -2.83%
    Narrow Range Bar Range Contraction -2.83%
    Older End-of-Day Signals for AEON ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 1 day ago
    1.5x Volume Pace 2 days ago
    Down 3% 2 days ago
    Fell Below Previous Day's Low 2 days ago
    Down 2 % 2 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    AEON Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Botulinum Toxin Dystonia

    Is AEON a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 AEON Biopharma GAAP EPS of -$0.16
    Nov 13 AEON Biopharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update
    Aug 19 AEON Biopharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 2024
    Aug 13 AEON Biopharma reports Q2 results
    Jul 16 Why Match Group Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
    Jul 9 AEON Biopharma announces strategic reprioritization for ABP-450
    Jul 9 AEON Biopharma Announces Strategic Reprioritization to Pursue a Biosimilar Pathway for ABP-450
    May 29 Down -64.16% in 4 Weeks, Here's Why AEON Biopharma, Inc. (AEON) Looks Ripe for a Turnaround
    May 29 AEON Biopharma Announces Strategic Resource Reprioritization and Cost Reduction Plan
    See more AEON news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 17.17
    52 Week Low 0.55
    Average Volume 152,303
    200-Day Moving Average 3.71
    50-Day Moving Average 0.90
    20-Day Moving Average 0.81
    10-Day Moving Average 0.68
    Average True Range 0.08
    RSI (14) 26.47
    ADX 25.6
    +DI 13.95
    -DI 34.06
    Chandelier Exit (Long, 3 ATRs) 0.81
    Chandelier Exit (Short, 3 ATRs) 0.79
    Upper Bollinger Bands 1.10
    Lower Bollinger Band 0.51
    Percent B (%b) 0.09
    BandWidth 74.09
    MACD Line -0.11
    MACD Signal Line -0.08
    MACD Histogram -0.0268
    Fundamentals Value
    Market Cap 20.94 Million
    Num Shares 37.2 Million
    EPS -2.39
    Price-to-Earnings (P/E) Ratio -0.24
    Price-to-Sales 97.16
    Price-to-Book 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.64
    Resistance 3 (R3) 0.64 0.62 0.62
    Resistance 2 (R2) 0.62 0.60 0.62 0.62
    Resistance 1 (R1) 0.59 0.59 0.58 0.59 0.62
    Pivot Point 0.57 0.57 0.57 0.57 0.57
    Support 1 (S1) 0.54 0.55 0.53 0.54 0.51
    Support 2 (S2) 0.52 0.54 0.52 0.51
    Support 3 (S3) 0.49 0.52 0.50
    Support 4 (S4) 0.49